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The quantity of envelope glycoprotein molecules (Env) on HIV-1 particles is still an issue of debate and, depending on the strain of virus
and the nature of the producer cells, it can vary greatly. Here, we have attempted to address how Env density influences HIV-1 fitness. To this
aim, we have produced HIV-1-derived viral particles with various amounts of R5 Env (low Env: Envlo; high Env: Envhi), using a regulatable
expression system. The infectivity was assayed on human cells, engineered to express the HIV receptor CD4 and the co-receptor CCR5, as
well as on peripheral blood lymphocytes and macrophages. In these experiments, low levels of Env were sufficient for cell infection, albeit at
low efficiency. Increasing the amount of Env resulted in cooperatively improved infectivity, but a threshold was rapidly attained, indicating
that only a fraction of Env was required for efficient infection. Unexpectedly, Env incorporation beyond what gives maximal infection
transiently stimulated the expression of proviral genes, as well as retrovirus production, in newly infected cells. This was likely a
consequence of induced NF-nB activity, as this transcription factor is triggered by Envhi, but not by Envlo, virions. Thus, our data suggest that
one major effect of high Env density on the surface of HIV may not be better infection yields but rather improved viral production by newly
infected cells.
D 2004 Elsevier Inc. All rights reserved.
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HIV-1 is the primary cause of AIDS and associated
diseases (Piot et al., 2001; Pomerantz and Horn, 2003;
Stevenson, 2003; Weiss, 2001). Its envelope glycoprotein
(Env) is responsible for virus binding to target cells, as well
as for mediating fusion between the viral envelope and the
host cell membrane (Poignard et al., 2001). HIV Env is a
heterodimer of two non-covalently linked glycosylated0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.031
Abbreviations: PBS, Phosphate-buffered saline; Dox, doxycycline; Env,
envelope glycoprotein; MWCO, molecular weight cut-off.
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1 Equally contributing co-authors.subunits (gp41 and gp120) proteolytically produced from
the same precursor (gp160) (Poignard et al., 2001). gp120
(or SU) is a surface molecule responsible for specific virus
attachment to cells, whereas gp41 is a transmembrane
protein that tethers Env to the viral envelope and carries the
fusion activity. gp120 and gp41 can dissociate, causing
shedding of gp120 from the viral surface. Although this
mechanism is probably less efficient than initially believed
(Chertova et al., 2002), it has been proposed to reduce virion
infectivity (McKeating et al., 1991; Poignard et al., 2001).
Envs trimerize to form the viral spikes, visible in electron
microscopy, which are thought to be the functional units for
specific binding of viruses to cells (Poignard et al., 2001).
The interaction of Env with its protein partners is
relatively well documented. Within immature virions, the05) 418–429
E. Bachrach et al. / Virology 332 (2005) 418–429 419cytoplasmic tail of gp41 interacts with Gag, which reduces
Env fusion activity until capsid maturation (Wyma et al.,
2004). With regard to the infection process, gp120 binds to
the CD4 molecule, which is the primary HIV receptor found
on a variety of cells, including T lymphocytes, dendritic
cells and macrophages/monocytes (Berger et al., 1999).
Different chemokine receptors serve as co-receptors, the
main ones being CCR5 and CXCR4, which permit infection
by the R5 and X4 HIV-1 isolates, respectively (Baribaud
and Doms, 2001; Berger et al., 1999). The change in HIV-1
cellular tropism plays an important role in disease pro-
gression and is driven, at least in part, by the selective
pressure of the immune system acting in conjunction with
the natural variation of the HIV genome (Cohen et al., 1997;
Moore et al., 1997). The primary clinically latent stages are
associated with R5 species, whereas during the disease X4
viruses may emerge (Cohen et al., 1997; Moore et al., 1997;
Paxton and Kang, 1998). The association of gp120 with
CD4 elicits a conformational change in Env, unveiling the
co-receptor binding site. Then, the association of the gp120–
CD4 complex with the relevant co-receptor results in further
structural rearrangements in gp41, which in turn permit
fusion between the viral and the host cell membranes
(Berger et al., 1999; Poignard et al., 2001).
Importantly, intracellular signaling cascades are triggered
by the interaction of the virus with both CD4 and the co-
receptors (Freedman et al., 2003; Popik and Pitha, 2000;
Stantchev and Broder, 2001). However, how this signaling
affects the physiology of infected cells and the establish-
ment of viral infection is not yet completely clear.
Conversely, the infected cell can influence the expression
of proviral genes. Together with viral components, cellular
transcription factors interact with the cis-acting elements of
the HIV promoter and regulate gene transcription according
to physiological changes, such as cell stimulation or
induction of division and differentiation (Pereira et al.,
2000; Roebuck and Saifuddin, 1999; Rohr et al., 2003). Of
particular note, two NF-nB transcription factor binding sites
reside within the HIV-1 LTR. Although not absolutely
necessary for basal transcription, they respond to cellular
activation signals by stimulating LTR activity and, thereby,
increase the rate of viral production (Berger et al., 1999).
The initial steps of infection are qualitatively well
understood, whereas the quantitative parameters are still
relatively ill defined. The number of CCR5 molecules
required for a successful interaction with Env has been
shown to depend on the availability of CD4 (Kuhmann et al.,
2000) and determines post-entry efficiency of R5 HIV-1
infection (Lin et al., 2002). However, the number of Env
trimers actually required to mediate infection is still unclear
and the quantity of Env on the surface of HIV-1 is, in itself, a
topic of controversy. Electron microscopic (EM) analysis
initially suggested that approximately 72 spikes were
incorporated into virions (Gelderblom, 1991). On the basis
of a biochemical analysis, a lower number (7–14) of spikes
per virion was also proposed (Chertova et al., 2002; Zhu etal., 2003). Other data consistent with this finding were also
published but, in addition, described significantly lower Env
contents for several laboratory-adapted strains and primary
isolates (Hammonds et al., 2003). In these experiments, the
Env value was deduced from the measurement of the Gag-to-
Env ratio, assuming that HIV particles contain 1200–2500
Gag copies. Recent cryo-EM and scanning transmission EM,
however, rather indicated a content of 5000 Gag proteins per
virions (Briggs et al., 2004), suggesting that the amount of
Env may have been underestimated by 2–4 fold in the
Chertova et al.’s, Zhu et al.’s, and Hammonds et al.’s reports.
Whatever the case, the number of Envs that can be
incorporated into viral particles is limited, including for
those produced by 293T cells, which are classically used to
generate pseudovirions, with a minimal Gag-to-Env ratio of
45:1 to 70:1 (Hammonds et al., 2003). Interestingly, the
limiting factor is not gp160 expression level by HIV-
producing cells but another still-to-be-identified mechanism
(Hammonds et al., 2003).
Here, we have aimed at determining to which extent Env
density at the virion surface is a critical parameter of HIV
infectivity. As various viral components can influence virus
infection/activity in a difficultly quantifiable manner, we set
out to investigate the effects of differences in SU quantity
while keeping all other viral factors constant. HIV-1
particles with different Env contents were produced in 293
TetOn cells under standardized conditions and both their
efficacy of infection and proviral expression in newly
infected cells were subsequently compared. Our data
support the idea that a limited amount of Env molecules is
sufficient to achieve infection, albeit at low efficiency, and a
cooperation between a small fraction of Envs is sufficient to
obtain maximal efficiency. Importantly, increasing the
quantity of Env above the level that yields the maximum
infectivity induces expression of LTR-driven genes in newly
infected cells, most probably via protracted NF-nB pathway
activation. The potential consequences of these observation
on the initial events of cellular infection by HIVand on viral
production by newly infected cells are discussed.Results
Infection efficiency of virions with different R5 Env amounts
As R5 viruses are the predominant species during
viremia establishment in infected individuals, we chose to
study the AD8 strain R5 Env (Cho et al., 1996). Since it is
not possible to purify homogenous populations of natural
HIV particles displaying different amounts of Env, we
resorted to a replication-incompetent EGFP reporter gene-
expressing HIV-1 vector (pHR-TE), which achieves one
round of infection and permits direct scoring of infected
cells through fluorescence analysis. Virions were produced
in 293 TetOn cells, stably expressing the doxycyclin (Dox)-
activatable rtTA transcription transactivator (Baron and
E. Bachrach et al. / Virology 332 (2005) 418–429420Bujard, 2000), after cotransfection with (i) CMVDR8.9, a
HIV-1-derived packaging plasmid (Zufferey et al., 1997),
(ii) the HIV-1 pHR-TE vector expressing constitutively the
CMV promoter-driven EGFP gene, and (iii) PM636,
carrying a rtTA-responsive AD8 Env gene (Fig. 1A) in
the presence of increasing concentrations of Dox. To verify
Env dose-dependent expression, immunoblotting experi-
ments were performed 48 h after transfection, using a
specific anti-gp120 Env antiserum. Env quantities in cell
lysates, as well as in extracts from CaCl2-precipitated
secreted proteins, varied as a function of Dox. However,
due to the intrinsic leakiness of the tetracycline expression
system, a basal level of Env expression could be observed,
even in the absence of Dox, (Fig. 1B). Variations in absolute
quantities of Env at a given Dox concentration were
observed between the different experiments (for example,
compare Fig. 1B with Fig. 2C), but they did not influence
the final conclusions. Flow cytometry analysis of trans-Fig. 1. HR-TE virions with different Env amounts. (A). Structure of expression pla
gene and no packaging signal. HIV-1 LTRs have been replaced by both the constitu
is an HIV-1-based vector expressing the EGFP gene under the control of the CM
abundance in virus-producing cells and viral particles as a function of Dox conce
various concentrations of Dox, with CMV7DR8.9, pHR-TE and PM636. Env abun
using an anti-gp120 antiserum 2 days post-transfection. Both the gp160 Env precur
detected in viral particles (c). The identity of gp160 and gp120 in cells was conf
same gel before immunoblotting analysis (not shown). The blots were stripped an
precursor in cells (b) and the processed p24Gag capsid protein in virions (d) to ver
indicates control cells transfected with pHR-TE and CMVDR8.9. Densitometer s
(C) Flow cytometry analysis of Env-expressing 293 TeTOn cells. Cells, 5  105
analyzed by flow cytometry using the 2G12 anti-gp120 monoclonal antibody.fected cells was also performed to analyze cell surface-
associated AD8 gp120 at the individual cell level (Fig. 1C).
Transfected cells were found in sharp peaks of fluorescence,
whereas non-transfected cells showed no fluorescence. The
mean fluorescence ratio of these peaks (4.3 between 1000
and 100 ng Dox/ml and 3 between 100 and 10 ng Dox/ml)
was comparable to the ratio of AD8 gp120 Env abundances
(4 between 1000 and 100 ng Dox/ml and 3.4 between 100
and 10 ng Dox/ml) assayed by cell extract immunoblotting
analysis (Fig. 1Ba), demonstrating a Dox dose-dependent
expression of AD8 gp120 by transfected cells.
Hos-CD4-CCR5hi cells are human osteogenic sarcoma
cells engineered to express CD4 and high quantities of
CCR5 for easy R5 virus infection studies and sorted for
homogenous CCR5 expression (Kato et al., 1999; Lin et al.,
2002). Standard virus assays (cfu assay) in which serial
dilutions of viral suspensions were placed in the presence of
an excess of target cells were conducted (Fig. 2A) and viralsmids. CMVDR8.9 (a) is an HIV-1-derived packaging plasmid with no env
tive CMV promoter and a heterologous polyadenylation signal. pHR-TE (b)
V promoter. PM636 (c) carries a rtTA-responsive AD8 Env gene. (B). Env
ntration. 293 TetOn cells were transiently cotransfected, in the presence of
dance in cell extracts and in purified virions was assayed by immunobloting
sor and the processed gp120 are detected in cells, (a) whereas only gp120 is
irmed by electrophoresing cellular and viral extracts in parallel through the
d reprobed with an anti-Gag protein antibody detecting the HIV-1 Pr55Gag
ify that comparable amounts of viral proteins were analyzed in all tracks. C-
canning analysis was performed using appropriately exposed luminograms.
, corresponding to the immunoblotting experiment presented in B (a) were
Fig. 2. Infection of Hos-CD4-CCR5hi cells, PBLs and macrophages by HR-TE virions. (A). Cfu assay on Hos-CD4-CCR5hi cells. The virions with different
Env contents in Fig. 1 were used for triplicate infections of Hos-CD4-CCR5hi in the cfu assay. Relative Env abundances are the average of three
immunoblotting assays and were deduced from densitometer scanning analysis of appropriately exposed luminograms. One hundred percent corresponds to
Env content of viruses prepared in the presence of 1000 ng Dox/ml, which was the maximal abundance that could be obtained. Error bars represent the standard
deviation. (B). Infection of PBLs. The same viruses as those used in Awere used to infect human PBLs. Infection was monitored through EGFP fluorescence
assay by flow cytometry. Two parallel experiments using 2  106 cells were conducted with the same final outcomes. Both the percentages of infected cells and
the mean fluorescence values per cell are indicated in the experiment presented. (C) Infection of macrophages. Three new HR-TE virion batches were produced
in the presence of 0, 100, and 1000 ng Dox/ml. Their relative Env contents were 1, 2, and 16. The two virions preparations with the highest Env contents were
equally infectious in the cfu assay (approximately 104 cfu/ml), whereas that with the lowest Env content was 100-fold less infectious. Infection of differentiated
macrophages obtained was monitored by flow cytometry as in B using 3  105 cells.
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infection was detected in the presence of particles produced
in the absence of the PM636 Env expression vector.
Moreover, there was no linear relationship between Env
abundance and infection efficiency. The 2-fold increase in
Env levels between 0 and 10 ng Dox/ml conditions resulted
in a 100-fold improvement of infectivity. However, the 2.6-
fold (between 10 and 100 ng Dox/ml) and the 2.5-fold
(between 100 and 1000 ng Dox/ml) rise in Env densities did
not result in any significant increase in infection. Similarly,
when infections were analyzed by flow cytometry (not
shown), the same percentages of cells (approximately 30%)Fig. 3. Infection of Hos-CD4-CCR5hi and macrophages by NL4-3.HSA.R+E- vir
genome where (i) the env gene is mutated and inactive and (ii) CD24 is inserted w
different Env amounts. Culture supernatants containing NL4-3.HSA.R+E- virio
membranes. Concentrated virions and filtrates were tested by immunoblotting for
Infection of Hos-CD4-CCR5hi cells. Hos-CD4-CCR5hi cells, 5  104, infected w
expression at different times post-infection. Relative amounts of Env in virions pre
ml were 1, 2, 5 and 12, respectively. The experiment presented is representati
macrophages were infected using virus preparations produced in the presence of 0,
respectively. Flow cytometry analysis was performed as in C using 3  105 cellswere positive whether viruses were produced in the
presence of 10, 100, or 1000 ng Dox/ml, whereas no
infection was detectable with viruses produced in the
absence of Dox. As flow cytometry is a less sensitive
method than the cfu assay, this lack of infection is consistent
with the 100-fold titer difference seen in the cfu experiment.
We next conducted experiments with natural HIV-1 target
cells, that is, human peripheral blood lymphocytes (PBL)
and primary macrophages. Suboptimal transduction con-
ditions were chosen to avoid potential saturation, while still
obtaining a reference level well above non-specific back-
ground. Using the same viral preparations as in Fig. 2A,ions. (A) pNL4-3.HSA.R+E- vector. The vector contains the entire HIV-1
ithin the nef gene. (B) Preparation of soluble gp120-free virions displaying
ns with different Env amounts were filtered through 1  106 MWCO
the presence of gp120, gp41 and p24 proteins using specific antibodies. (C)
ith the virions presented in B and analyzed by flow cytometry for CD24
pared in the presence of 0 (: : :), 10 (- - -), 100 (—) and 1000 ( ) ng Dox/
ve of 3 independent experiments. (D) Infection of macrophages. Human
100, and 1000 ng Dox/ml and displaying relative Env ratios of 1, 2, and 18,
.
Table 1
Quantitative PCR on genomic DNA from cells infected with viral particles
expressing different quantities of Env
Sample (n = 6) 0 ng/ml
Dox
10 ng/ml
Dox
100 ng/ml
Dox
1000 ng/ml
Dox
Provirus AUa 6 769 F 188 943 F 82 1004 F 89
a Arbitrary units: provirus-to-control DNA ratio (see Materials and
methods). The amplified pro-virus signals are expressed as a function of
CCR5.
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virions produced in the presence of either 10, 100, or 1000
ng Dox/ml, whereas virions produced in the absence of Dox
did not detectably infect the cells. (Fig. 2B). New batches of
virus were prepared, and likewise, we did not observe any
infection of macrophages by virions produced in absence of
Dox, although viruses with 2- and 16-fold higher Env
contents appeared equally infectious (Fig. 2C).
Taken together, our data indicate that (i) a limited Env
amount is sufficient to permit infection by HIV-1, albeit at
low efficiency, (ii) a slight increase in Env incorporation
results in a dramatic improvement of cell infection
indicative of cooperation between Envs, and (iii) a threshold
of Env density above which no improvement in cell
infection is observed is rapidly reached.
Differential HIV-1 LTR activation in cells infected by virions
with different Env amounts
Binding of soluble and cell membrane-exposed gp120 to
HIV receptor and co-receptors can activate intracellular
signaling (Freedman et al., 2003; Popik and Pitha, 2000;
Stantchev and Broder, 2001). We, therefore, assessed here
whether virions with different Env levels could alter signal-
ing as well and, thereby, influence HIV provirus expression
in recently infected cells. The pNL4-3.HSA.R+E-HIV-1-
derived vector (Fig. 3A) contains the entire HIV genome
with a mutated, non-functional env gene and the CD24
(HSA) cell surface glycoprotein cDNA, inserted into the nef
gene and consequently transcribed from the LTR. Impor-
tantly, the change in the promoter controlling reporter protein
gene transcription allows for both the identification of
infected cells and the assay of provirus expression levels in
the same CD24-based flow cytometry experiment. To
concentrate the virus and exclude small molecules, including
soluble Env and Dox, culture supernatants from transfected
293 TetOn cells were filtered through 1  106 MWCO
membranes (Fig. 3B). Hos-CD4-CCR5hi cells were infected
and flow cytometry analysis was performed 1, 3, and 7 days
later (Fig. 3C). As above (Fig. 2), retroviruses produced in
the absence of Dox gave no detectable infection, albeit low-
efficiency transduction occurred in the cfu assay (not
shown). Again, the percentages of infected cell were in the
same range for all other conditions of production, regardless
of the day of analysis. However, 1 day post-infection, CD24
expression levels were elevated when Env incorporation was
high: in the presence of 100 and 1000 ng Dox/ml, CD24 was
50% and 130% higher, respectively, than with 10 ng Dox/ml.
This effect is no longer detectable after 3 and 7 days.
Pseudotransduction of cell surface molecules from retro-
virus-producing cells to the membrane of infected cells has
already been reported to bias gene transfer experiments
(Gallardo et al., 1997). However, very low and identical
basal levels of CD24, the level of which was not reduced in
the presence of AZT, were associated with purified virions,
regardless of the Dox concentration (not shown), indicatingthe absence of pseudotransduction by the lentiviral vectors
used. Hence, co-transport of CD24 with Env is not
accountable for the effects observed on day 1. Southern
blotting analysis of high molecular weight DNA prepared
from infected cell showed that comparable amounts of
proviruses were generated upon infection with virions
produced in the presence of 10, 100, and 1000 ng Dox/ml
(data not shown). Also, this was further demonstrated with
real-time PCR, confirming that the viral copy numbers in the
differently infected cells were in the same range (Table 1).
Hence, this difference in CD24 expression is not a result of
more productive infections. Therefore, we tested the
hypothesis that Envhi virions could stimulate HIV gene
expression more efficiently than EnvLo virions.
For this purpose, we looked at the LTR-activation in
natural target cells for HIV-1, infected with Envlo and Envhi
viruses. To obtain differentiated macrophages, purified
monocytes were induced by VitD3, a differentiating agent
for myelomonocytic cell that does not trigger HIV-1
expression (Goletti et al., 1995). The cells were incubated
with virions, which carried relative Env contents of 1 (0 ng
Dox/ml), 2 (100 ng Dox/ml) and 18 (1000 ng Dox/ml),
respectively. Consistent with our previous results, we did
not detect any infected cells using Envlo particles, whereas
infection efficiencies of the other two virus (100 and 1000
ng Dox/ml) preparations were comparable (Fig. 3D). Again,
there was a significant (3-fold) difference in CD24
expression between the two infectious samples. Thus,
stimulation of proviral expression by high Env density
virions is not restricted to Hos-CD4-CCR5hi cells but also
pertains to natural HIV targets.
Higher viral protein production by cells newly infected by
virions with high Env content
Next, we asked if higher proviral expression in recently
infected cells by Envhi virions resulted in increased viral
production. Three NL4-3.HSA.R+E- viral batches with
relative Env contents of 1, 2, and 12 were produced. Again,
the virus preparation with lowest Env density was poorly
infectious, whereas the other two were equally infectious on
Hos-CD4-CCR5hi cells. As expression of the viral proteins
in infected cells are driven by the LTR, the amount of Gag
protein precursor (Pr55Gag) in cell extracts directly reflects
provirus expression, whereas that of mature Gag (p24Gag)
in culture supernatants mirrors viral particle release from
E. Bachrach et al. / Virology 332 (2005) 418–429424cells. p24Gag and Pr55Gag were assayed by immunoblot-
ting 24 h post-infection and only detected when using the
two most infectious viral preparations. As predicted, the
most elevated protein levels were found in cells infected
with virus bearing maximum Env density (Fig. 4A).
Similar experiments were conducted with human primary
macrophages, using viruses with relative Env levels of 1, 2,
and 18. Pr55Gag was detectable, albeit at a low level,
exclusively in cells infected by virions expressing the
highest levels of Env, whereas p24Gag was not detected
in any conditions (Fig. 4B). This is not surprising, as
production of viral particles by infected macrophages occursFig. 4. NF-nB activation, provirus expression and viral particles production
in cells infected by virions with different Env contents. (A) Viral particles
production by newly infected Hos-CD4-CCR5hi cells. Hos-CD4-CCR5hi
cells were infected with virions displaying 1 (+), 2 (++), and 12 (+++)
relative levels of Env. The latter two preparations were equally infectious
and the former one poorly. Pr55Gag and p24 Gag abundances were assayed
by immunoblotting using a specific anti-Gag antiserum in cell extracts and
purified viral particles, respectively, 24 h post-infection. (B) Proviral
expression in newly infected macrophages. The experiments were
conducted as in B except that relative amounts of Env in virion preparations
were 1 (+), 2 (++) and 18 (+++). (C) NF-nB activation in Hos-CD4-CCR5hi
cells. Hos-CD4-CCR5hi cells were transiently transfected with conaluc and
(Ign)3-conaluc plasmids. Twenty-four hours later, they were infected for 6 h
using two populations of NL4-3.HSA.R+E- virions showing a 6-fold
difference in Env content but similar infectivity. Luciferase activity was
measured 6, 24, and 48 h post-infection. The presented data are the average
of three experiments. (+) and (+++) correspond to virons expressing low
and high Env amounts, respectively. The reference activity of 1 corresponds
to the basal NF-nB activity in non-infected Hos-CD4-CCR5hi cells assayed
using (Ign)3-conaluc. The error bar represents the standard deviation.at a much slower rate than that of infected Hos-CD4-
CCR5hi cells (Li et al., 1999; Naif et al., 1999). Analysis to
detect viral particle release at later time points could not be
performed because of culture degeneration. Nevertheless,
these data indicate that viral expression was increased in
cells infected by virions with a high Env content.
Different activation of the NF-jB pathway by Envlo and
Envhi HIV-1 virions
As the NF-nB pathway is implicated in HIV-1 LTR
activation, we finally investigated whether this cascade
could be differently affected in cells infected by either Envhi
or Envlo virions. Hos-CD4-CCR5hi cells were transfected
with reporter plasmids expressing the firefly luciferase gene
from either a minimal constitutive (conaluc) or a NF-nB-
inducible ((Ign)3-conaluc) conalbumin promoter. The cells
were incubated with two populations of NL4-3.HSA.R+E-
particles, from where soluble gp120 had been excluded. The
virus preparations displayed a 6-fold difference in Env
content, but had the same infection efficiency (not shown).
Luciferase activity was assayed in cell extracts prepared 6,
24 and 48 h after a 6-h infection. No (1.2-fold) stimulation
of the NF-nB pathway was observed when infections were
performed with the lowest Env density particles (Fig. 4C).
In contrast, NF-nB activity was stimulated at all time points
tested with a peak of activity (8-fold stimulation) 24 h post-
infection using the highest Env density virus preparation.
This activity was comparable to that measured 6 h post-
stimulation by TNF-a in control experiments (not shown).
We also assayed pseudotyped NL4-3.HSA.R+E- virions
expressing 4-fold different amounts of the amphotropic
murine leukemia virus Env. Both vectors were equally
infectious on Hos-CD4-CCR5hi cells, indicating that this
particular Env can also be incorporated in apparent excess
with regard to maximal infection efficiency. However,
neither induced NF-nB activity (not shown), pointing to a
specific effect of HIV Env with regard to differential
activation of this pathway.Discussion
Here, we have evaluated how different Env contents can
influence virus fitness and viral production by newly
infected cells as this might help predicting the propagation
of certain virus isolates and, ultimately, the progression of
AIDS.
Influence of Env density on cell infection
Several lines of evidence have long supported the idea
that a large fraction, if not most, of Env on virions is
required for cell infection by HIV. For example, initial
infection-blocking experiments using soluble CD4 (sCD4)
(Layne et al., 1990) and neutralizing monoclonal antibodies
E. Bachrach et al. / Virology 332 (2005) 418–429 425(mAb) (Parren and Burton, 2001; Schonning et al., 1999)
have suggested that approximately 50% and 60%, respec-
tively, of natural Env levels were required for infection.
Moreover, major losses of infectivity as virions ages were
observed in association with only relatively small losses of
gp120 from virions (McKeating et al., 1991).
Contrasting with this view, our data rather suggest that (i)
a small fraction of the Env amount that can be incorporated
by HIV-1 particles is sufficient for infection, albeit at low
efficiency, (ii) a higher, but still limited, number of Envs can
cooperate for maximal infection and (iii) an bapparentQ vast
excess of Env is incorporated into viral particles. Although
it is difficult to formally rule out that low-efficiency
infection by Envlo viruses reflect infection by a small
fraction of viruses with a higher Env content, it is important
to underline that similar observations were previously made
with murine leukemia viruses (Bachrach et al., 2000).
Moreover, using mAbs as molecular probes, Poignard et al.
(2003) recently demonstrated that a fraction of Envs
expressed on primary HIV-1 isolates is non-functional,
which also strengthens the notion that only part of envelope
glycoproteins exposed on the surface of HIV particles is
sufficient for infection. Additional work is still needed to
precisely quantify this fraction and to determine whether it
corresponds to misfolded or non-multimerized molecules.
However, this will constitute a difficult task for at least two
reasons. First, the number of Env carried by natural HIV
particles is still a matter of controversy (see Introduction).
Second, if quantification of the number of Env molecules on
high Env density-displaying virions is technically feasible,
that on Envlo particles still necessitates methodological
improvements. Importantly, we do not feel that our Envhi
viruses corresponded to viruses with supraphysiological
contents of Env for two reasons: (i) a limit to the Env
amount that can be incorporated into HIV-1 virions is
rapidly attained and corresponds to levels found in several
natural strains and isolates, albeit the molecular reasons for
this still remains to be determined (Hammonds et al., 2003)
and (ii) a preliminary analysis has shown that the maximal
amount of Env incorporated in our Envhi virions was
comparable to that harbored by a primary isolate (not
shown). Although comparison with a larger sampling of
primary isolates and laboratory strains is still required for
precise quantification, these arguments led us to speculate
that only a few spikes (and maybe just one) are sufficient for
low efficiency infection.
The mechanisms underlying synergy between a few Envs
for efficient infection are still unknown and may be
multiple. Further work will address whether they involve
concerted actions between Env monomers within spikes
and/or cooperation between spikes for recruiting several
receptors/co-receptors or forming more efficient fusion
pores. Cooperation between SU and TM Env components
and/or between Env monomers is possible as different Env
mutants can reciprocally complement their defects within
mixed oligomers (Salzwedel and Berger, 2000). Recentelectron microscopy analysis revealed relatively uniform
spacing of Env trimers at the surface of HIV virions and
provided no evidence for physical association of spikes
(Zhu et al., 2003). However, the authors did not formally
exclude the possibility of functional collaboration between
spikes as it is not clear yet whether spacing between Envs
was due to actual structural constraints imposed by the
underlying viral matrix proteins or to technical reasons, such
as insufficient number of analyzed particles, insufficient
sensitivity of the method or unavoidable deformations
resulting from electron microscopy sample preparation
(Zhu et al., 2003). Finally, it is worth underlining that the
dynamics of Env multimerization on the viral surface has,
thus far, not been investigated in-depth. Therefore, it is
possible that Env oligomers may dissociate and reassociate
on the viral surface and that cooperativity reflects facili-
tation of functional spike formation above a certain Env
density threshold.
In our experiments, approximately 80% of Envs incor-
porated into virions appeared dispensable for cell infection.
An important question is whether a similar fraction is also
dispensable in natural in vivo situations. At that stage of
investigation, we do not exclude that it may differ
significantly and vary among the different virus strains for
a variety of reasons. Firstly, it has been shown that
expression of CD4 in virus-producing cells can reduce the
infectivity of HIV virions (Arganaraz et al., 2003; Levesque
et al., 2003), presumably by blocking the CD4-binding
domain of Env via the formation of CD4–Env complexes at
the surface of HIV. As no CD4 is expressed by 293T cells,
this factor was not taken into consideration in our experi-
ments. It is therefore possible that the presence of CD4 in
vivo increases the dependence upon incorporation of higher
amounts of Env and, thereby, affects the fraction of Env not
necessary for/involved in the infection process. Production
of HIV particles by 293T cells expressing varying amounts
of CD4 will allow to address this issue. Secondly, Env from
laboratory-adapted strains usually display higher affinity for
CD4 than Env from primary isolates (Kozak et al., 1997;
Platt et al., 1997). It is therefore conceivable that a higher
number of Env-receptor interactions is required for infection
by primary viruses and that, although the densities of CD4
and CCR5 at the surface of the Hos-CD4-CCR5hi cells were
quite physiological, their relatively high levels of expression
have masked this requirement. Experiments with Envs
cloned from primary isolates and indicator cells expressing
different levels of receptor and co-receptor should help
resolving this question.
Possible role(s) for the apparent Env excess
The reasons for the apparent excess of Env may be
multiple and non-exclusive. The most trivial explanation is
to keep an Env amount superior to that required for infection
to compensate for shedding. Moreover, it must be taken into
consideration that, as previously mentioned, a fraction of
E. Bachrach et al. / Virology 332 (2005) 418–429426Env is likely to be non-functionally exposed at the surface
of HIV particles (Poignard et al., 2003). In the specific case
of MLVs, we have shown that increasing Env density
accelerates the rate at which infectious attachment to cells
occurs without affecting the final infection outcome
(Bachrach et al., 2000). However, testing whether this also
holds true for HIV was impossible because the metastable
gp120–gp41 association does not resist the stringency of
cell washings used in infection kinetics experiments.
Nevertheless, as retroviruses adsorb onto cells in an Env-
independent manner (Pizzato et al., 1999) before browsing
the cell surface until viral receptor encounter, it is
reasonable to assume that high Env density increases the
frequency of this and, thereby, accelerates virus entry into
cells. This might provide Envhi virions with a selective
advantage in vivo because it reduces the chances of
inactivation by simple ageing or by the various clearance
systems. Env amounts high above that sufficient for
infection may also permit HIV to display highly redundant
decoys for neutralizing antibodies. Consistent with this idea,
efficient virus neutralization was proposed to require an
average of one antibody molecule per spike (Poignard et al.,
2001). It has also been proposed that the already mentioned
fraction of non-functional Env exposed at the surface of
HIV virions may stimulate the generation of non-neutraliz-
ing antibody (Poignard et al., 2003). Incorporation of more
Env than necessary for infection might, thus, represent an
additional advantage for HIV for biasing the humoral
antiviral response.
There is ample evidence that HIV-1 virus uses both CD4
and chemokine receptors to induce signaling that both
pertube the immune system (via mechanisms largely
contributed by soluble gp120) and facilitate the early stages
of infection (Freedman et al., 2003; Popik and Pitha, 2000;
Stantchev and Broder, 2001). Our work has unveiled
another unanticipated selective advantage for Envhi HIV
virions beyond the establishment of infection, as these, but
not Envlo particles, transiently stimulated proviral expres-
sion in newly infected Hos-CD4-CCR5hi cells and primary
macrophages. Consistent with the notion that NF-nB is of
particular importance for efficient HIV transcription, we
observed protracted NF-nB activity in Hos-CD4-CCR5hi
cells infected with Envhi, but not Envlo, particles. The Env
threshold as well as the signaling mechanisms and kinetics
involved deserve further investigations. Whatever the
explanation, it is tempting to speculate that infection by
Envhi viruses may entail better retroviral production in vivo
(at least for a certain period of time post-infection) and,
thereby higher viral load. Testing whether Env density
correlates with virus load and disease progression in
infected individuals would be interesting in this respect.
Not unexpectedly, we could not observe higher proviral
expression upon PBL infection by Envhi (not shown) as in
vitro infection necessitates prior cell activation (Korin and
Zack, 1998, 1999), which also induces sustained NF-nB
activation. However, it is unlikely that infection of T cells invivo occurs in the presence of such a high NF-nB activity
(Blaak et al., 2000; Eckstein et al., 2001; Zhang et al.,
1999). Therefore, it is possible that differential retroviral
production may happen upon infection of natural T cells by
viruses with different Env levels. Apart from NF-nB, free
gp120 is known to alter multiple other signaling cascades
via both CD4 and chemokine receptors (Berger et al., 1999).
Therefore, we do not exclude that high Env-displaying
virions may also stimulate other pathways influencing
proviral expression and/or infected cell physiology. Along
this line, it is worth noting that, at variance with CD4, which
is expressed in a narrow range, CCR5 cell surface
abundance varies among individuals and correlates with
both R5 HIV-1 infectivity in vitro (Platt et al., 1998), virus
load (Reynes et al., 2000), and disease progression in vivo
(Reynes et al., 2001). It would, thus, be interesting to study
whether variations in both viral Env- and cell surface CCR5
density can influence HIV propagation via mechanisms,
which could non-exclusively include cell entry efficacy and
perturbation of signaling pathways.Materials and methods
Plasmids
pRL-TK and pEGFP-C1 are from Clontech. The firefly
luciferase (Ign)3-conaluc and conaluc reporter plasmids are
described in Munoz et al. (1994) and CMVDR8.9 and
pNL4-3.HSA.R+E- in Zufferey et al. (1997) and He et al.
(1995), respectively. pHR-TE was constructed by replacing
lacZ from pHR-CMVlacZ (Naldini et al., 1996) by EGFP
from pEGFP-N1 (Clontech) and PM636 by inserting the
AD8 Env gene of pCMVAD8env (Cho et al., 1996) into
pUHD-10-3 (Baron and Bujard, 2000).
Cell lines and primary cells
293 TetOn and Hos-CD4-CCR5hi cells are from Clontech
and the NIH AIDS Research and Reference Reagent
Program (NARRRP), respectively. They were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 100 units/ml streptomycin, 100 units/ml
penicillin, 2 mM l-glutamine and 10% heat-inactivated
fetal calf serum (Gibco-BRL) (Hos-CD4-CCR5hi cells) or
Tet System-Approved Fetal Bovine Serum (Clontech) (293
TetOn cells). Importantly, 293 cells produce little micro-
vesicles that could possibly incorporate viral proteins
(Hammonds et al., 2003) and complicate the interpretation
of our results. Mononuclear human cells were isolated from
informed healthy donor fresh blood samples by Ficoll–
Paque density gradient centrifugation. PBLs cells, 107, were
induced in 5 ml of RPMI 1640 medium (Gibco/BRL),
containing 10% heat-inactivated fetal calf serum, 100 units/
ml streptomycin, 100 units/ml penicillin, 2 mM L-gluta-
mine, 5 Ag/ml of phytohemagglutinin (PHA, Difco) and 10
E. Bachrach et al. / Virology 332 (2005) 418–429 427U/ml of recombinant human IL-2 (Boehringer) for 36 h.
PHA and IL-2 were washed away once with RPMI medium
before infection. Monocytes were purified from peripheral
blood mononuclear cells by negative selection using
monoclonal antibodies for CD2, CD7, CD16, CD19, and
CD56 and magnetic beads (Dynal Biotech) and seeded at a
density of 3  105 cells/well in 12-well plates with RPMI
medium complemented with 107 M 1-alpha,-25-Dihydrox-
yvitamin D3 (VitD3) (Hoffmann-La Roche SA). Purified
cells, 97.4%, were CD1a, CD14+, CD32+, CD64. After
5 days, adherent cells were collected and stained using
phycoerythrine (PE)-CD1a and FITC-CD14 (Beckman-
Coulter) to confirm that they belonged to the macrophage
lineage.
Cell transfection and virus production
293 TetOn cell were transiently transfected using the
calcium phosphate coprecipitation procedure (Sambrook et
al., 1989). Cells, 2  105, per well of 6-well culture plates
(Nunc) were co-transfected using 3 Ag of each of the
relevant plasmids. Sixteen-hour post-transfection, cells were
washed three times with phosphate-buffered saline (PBS:
0.15 M NaCl, 0.01 M NaPO4, pH 7) and cultured in fresh
medium containing different concentrations of doxycycline.
Culture supernatants were collected 24 h later for further
experiments. To concentrate the virus and eliminate Dox
and soluble gp120, culture supernatants were centrifuged
through 1  106 MWCO columns (Sartorius) as specified
by the supplier. Preliminary experiments using a constitutive
expression vector for Env showed no inhibition of lentiviral
production at any of the Dox concentrations used here.
Flow cytometry analysis
Assays were performed using the FACScan device from
Becton Dickinson using 104 cells per sample. Env expres-
sion on 293 TetOn cells was analyzed as described
(Lavillette et al., 1998) using the 2G12 human anti-gp120
antibody (Park et al., 2000) obtained from the NARRRP and
a FITC-conjugated anti-human IgG1 antibody (Jackson
Immunoresearch Laboratories). As a negative control, cells
were incubated with the secondary antibody alone. HR-TE
virions-infected cells were scored through direct EGFP
fluorescence analysis. NL4-3.HSA.R+E- virions-infected
cells were identified after incubation at 4 8C for 30 min in
the presence of the phycoerythrine (PE)-conjugated (M1/69)
anti-mouse CD24 antibody (Becton Dickinson Pharmin-
gen). Cells were washed in PBS before analysis. Cells
incubated in the presence of the PE-conjugated anti-rat
IgG2b were used as a negative control.
Virus assay
Dox on its own was shown not to influence infection.
For Hos-CD4-CCR5hi cell cfu assay, 1  103 cells wereplated per well in a 96-well culture plate (Nunc). Twenty-
four hours later, the culture medium was replaced by fresh
culture medium containing serially diluted culture super-
natants or filtration-purified viruses in the presence of 8 Ag/
ml polybrene (Sigma). EGFP-positive cells were scored
under the fluorescence microscope 48-h post-infection and
titers were calculated from the appropriate dilution. For
FACS assays, 104 viral particles were used for infection.
For Hos-CD4-CCR5hi cells, 2  104 cells were plated in
12-well culture plates, infected for 24 h and FACS analysis
was carried out 48 h post-infection. For macrophage
infection, 3  105 differentiated cells were infected in
12-well culture plates (Nunc). Infections were allowed to
proceed for 16 h. The culture medium was changed and the
number of infected cells was quantified 24 h later.
Depending on the vector, either CD24 expression was
determined by flow cytometry or EGFP fluorescence was
measured by either flow cytometry or positive cells were
directly counted under the fluorescence microscope. For
PHA-activated PBL infection, 2  106 cells per well of 12-
well culture plates were placed in the presence of serial
dilutions of viruses. Infections were allowed to proceed for
90 min at 30 8C under rotation at 2500 rpm. Culture plates
were then transferred into an incubator and cells were
washed twice with PBS 16 h later and once with RPMI
medium. After 48 h in culture, they were analyzed by flow
cytometry.
Immunobloting assays
Viral and cell proteins were prepared and processed for
immunoblotting as described elsewhere (Bachrach et al.,
2000). For virion protein preparation, 1 ml virus-containing
culture supernatant samples were adjusted to 10 mM CaCl2
and left at 20 8C for 30 min. Precipitated viruses were spun
down at 15,000  g at 4 8C for 1 min and resuspended in
15 Al of electrophoresis loading buffer. For cell protein
preparation, cells were washed with PBS, scraped off
culture dishes, centrifuged at 1200  g at 4 8C for 5 min,
resuspended in triplex lysis buffer (50 mM Tris–HCl pH 8,
150 mM NaCl, 0.2% NaN3, 0.1% SDS, 1% NP40, 0.5%
Na deoxycholate, 2 mg/ml leupeptin, 1 mM phenylmethyl
sulfone fluoride) and left on ice for 30 min. Cell debris and
nuclei were removed by centrifugation (15,000  g at 4 8C
for 10 min). One hundred micrograms cell protein or equal
volumes of virus protein samples were processed for
immunoblotting analysis. For Fig. 3B, 10 Al of concen-
trated virions and 20 Al of filtrates were used per track. For
virion protein analysis, p24Gag was used as an internal
reference to normalize data. gp120, gp41, and Gag proteins
were detected using the DV-012 sheep polyclonal antibody,
the 240-DM mouse monoclonal antibody and the SF2
rabbit monoclonal antibody, respectively, from the
NARRRP. Densitometer analysis of appropriately exposed
luminograms was performed using the NIH IMAGE
software.
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Seven days after infection with pNL4-3.HSA.R+E-HIV-
1, genomic DNA from Hos-CD4-CCR5hi cells were
extracted as described (Lin et al., 2002). In brief, cells were
lysed in lysis buffer (10 mM Tris (pH 8), 0.5 mM EDTA,
0.0001% SDS, 0.001% Triton-X, 100 Ag/ml Proteinase K)
for 3 h at 50 8C, followed by 10 min at 95 8C and three
freeze–thaw cycles. Debris was removed by centrifugation
and quantitatively normalized DNA was amplified with
oligonucleotides specific for the (1) Strong-Stop (5V-
GCTCTCTGGCTAACTAGGGAAC-3V and 5V-TGAC-
TAAAAGGGTCTGAGGGAT-3V), (2) the 5V LTR
(GCTCTCTGGCTAACTAGGGAAC-3V and 5V-
CTCTGGCTTTACTTTCGCTTT -3V) and (3) the CCR5
gene (5V-CGTCGACTCTCCCCGGGTGGAACAA-3V and
5V-TGGAT-CCAAGCCCACAGATATTTCCTGC-3V) at 65
8C in a LightCycler (Roche Diagnostics) with SYBR green,
as recommended by the manufacturer. To quantify the
cellular DNA, the amplification was carried out so that the
signal was obtained in the exponential range.
NF-jB activation and luciferase assay
Hos-CD4-CCR5hi cells, 2  105, were seeded per well of
6-well culture plates and transfected 1 day later using the
calcium phosphate coprecipitation procedure with 2 Ag of
the relevant firefly luciferase reporter plasmid and 0.1 Ag of
the Renilla luciferase expression plasmid (Promega) used as
an internal transfection standard. Sixteen hours post-trans-
fection, cells were washed three times with PBS and
cultured for another 24 h, at which time they were subjected
to infection for 6 h, washed again 3 times with PBS before
replacing the culture medium. Firefly and Renilla luciferase
assays were performed using the Dual-Luciferase Reporter
Assay System (Promega).Acknowledgments
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